Up a level |
Johnson, Philip, Berhane, Sarah, de Groot, Emily, Toyoda, Hidenori, Tada, Toshifumi, Kumada, Takashi, Satomura, Shinji, Osaki, Yukio, Kudo, Masatoshi, Nishida, Naoshi et al (show 6 more authors)
(2020)
AFP is elevated more than 10 years before hepatocellular carcinoma development is detected: this observation leads to a practical risk stratification strategy.
.
Vogel, Arndt, Frenette, Catherine, Sung, Max, Daniele, Bruno, Baron, Ari, Chan, Stephen L, Blanc, Jean Frederic, Tamai, Toshiyuki, Ren, Min, Lim, Howard J et al (show 3 more authors)
(2021)
Baseline Liver Function and Subsequent Outcomes in the Phase 3 REFLECT Study of Patients with Unresectable Hepatocellular Carcinoma.
LIVER CANCER, 10 (5).
pp. 510-521.
Chan, Anthony WH, Zhong, Jianhong, Berhane, Sarah, Toyoda, Hidenori, Cucchetti, Alessandro, Shi, KeQing, Tada, Toshifumi, Chong, Charing CN, Xiang, Bang-De, Li, Le-Qun et al (show 7 more authors)
(2018)
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection.
Journal of hepatology, 69 (6).
1284 - 1293.
Chan, Anthony WH, Zhong, Jianhong, Berhane, Sarah, Toyoda, Hidenori, Cucchetti, Alessandro, Shi, KeQing, Tada, Toshifumi, Chong, Charing CN, Xiang, Bang-De, Li, Le-Qun et al (show 7 more authors)
(2018)
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection.
Journal of hepatology, 69 (6).
pp. 1284-1293.
Kudo, Masatoshi, Galle, Peter R, Brandi, Giovanni, Kang, Yoon-Koo, Yen, Chia-Jui, Finn, Richard S, Llovet, Josep M, Assenat, Eric, Merle, Philippe, Chan, Stephen L et al (show 11 more authors)
(2021)
Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2.
JHEP REPORTS, 3 (2).
100215-.
Kudo, Masatoshi, Ueshima, Kazuomi, Ikeda, Masafumi, Torimura, Takuji, Tanabe, Nobukazu, Aikata, Hiroshi, Izumi, Namiki, Yamasaki, Takahiro, Nojiri, Shunsuke, Hino, Keisuke et al (show 17 more authors)
(2022)
Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarteria Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma.
LIVER CANCER, 11 (4).
pp. 354-367.
Park, Joong-Won, Chen, Minshan, Colombo, Massimo, Roberts, Lewis R ORCID: 0000-0001-7885-8574, Schwartz, Myron, Chen, Pei-Jer, Kudo, Masatoshi ORCID: 0000-0002-4102-3474, Johnson, Philip ORCID: 0000-0003-1404-0209, Wagner, Samuel, Orsini, Lucinda S et al (show 1 more authors)
(2015)
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.
Liver international : official journal of the International Association for the Study of the Liver, 35 (9).
pp. 2155-2166.
Ueshima, Kazuomi, Nishida, Naoshi, Hagiwara, Satoru, Aoki, Tomoko, Minami, Tomohiro, Chishina, Hirokazu, Takita, Masahiro, Minami, Yasunori, Ida, Hiroshi, Takenaka, Mamoru et al (show 7 more authors)
(2019)
Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study.
CANCERS, 11 (7).
E952-.
Kudo, Masatoshi ORCID: 0000-0002-4102-3474, Finn, Richard S ORCID: 0000-0003-2494-2126, Qin, Shukui, Han, Kwang-Hyub, Ikeda, Kenji, Cheng, Ann-Lii ORCID: 0000-0002-9152-6512, Vogel, Arndt ORCID: 0000-0003-0560-5538, Tovoli, Francesco ORCID: 0000-0002-8350-1155, Ueshima, Kazuomi ORCID: 0000-0002-7577-5789, Aikata, Hiroshi ORCID: 0000-0002-3409-2156 et al (show 10 more authors)
(2023)
Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study.
Journal of hepatology, 78 (1).
pp. 133-141.
Verset, Gontran, Borbath, Ivan, Karwal, Mark, Verslype, Chris, Van Vlierberghe, Hans, Kardosh, Adel, Zagonel, Vittorina, Stal, Per, Sarker, Debashis, Palmer, Daniel H ORCID: 0000-0002-7147-5703 et al (show 16 more authors)
(2022)
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial.
CLINICAL CANCER RESEARCH, 28 (12).
pp. 2547-2554.
Han, Guohong, Berhane, Sarah, Toyoda, Hidenori, Bettinger, Dominik, Elshaarawy, Omar, Chan, Anthony WH, Kirstein, Martha, Mosconi, Cristina, Hucke, Florian, Palmer, Daniel ORCID: 0000-0002-7147-5703 et al (show 24 more authors)
(2020)
Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach.
Hepatology (Baltimore, Md.), 72 (01).
pp. 198-212.
Kudo, Masatoshi, Ueshima, Kazuomi, Ikeda, Masafumi, Torimura, Takuji, Tanabe, Nobukazu, Aikata, Hiroshi, Izumi, Namiki, Yamasaki, Takahiro, Nojiri, Shunsuke, Hino, Keisuke et al (show 18 more authors)
(2020)
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.
Gut, 69 (8).
pp. 1492-1501.
Hughes, David M ORCID: 0000-0002-1287-9994, Berhane, Sarah, Emily de Groot, CA, Toyoda, Hidenori, Tada, Toshifumi, Kumada, Takashi, Satomura, Shinji, Nishida, Naoshi, Kudo, Masatoshi, Kimura, Toru et al (show 6 more authors)
(2020)
Serum Levels of Alpha Fetoprotein Increased More Than 10 Years Before Detection of Hepatocellular Carcinoma.
Clinical Gastroenterology and Hepatology, 19 (1).
162-+.
Kudo, Masatoshi, Ueshima, Kazuomi, Yokosuka, Osamu, Ogasawara, Sadahisa, Obi, Shuntaro, Izumi, Namiki, Aikata, Hiroshi, Nagano, Hiroaki, Hatano, Etsuro, Sasaki, Yutaka et al (show 13 more authors)
(2018)
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.
LANCET GASTROENTEROLOGY & HEPATOLOGY, 3 (6).
pp. 424-432.
Kudo, Masatoshi, Finn, Richard S, Edeline, Julien, Cattan, Stephane, Ogasawara, Sadahisa, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Verslype, Chris, Zagonel, Vittorina, Fartoux, Laetitia, Vogel, Arndt et al (show 11 more authors)
(2022)
Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib.
EUROPEAN JOURNAL OF CANCER, 167.
pp. 1-12.
Toyoda, Hienori, Tada, Toshifumi, Johnson, Philip J ORCID: 0000-0003-1404-0209, Izumi, Namiki, Kadoya, Masumi, Kaneko, Shuichi, Kokudo, Norihiro, Ku, Yonson, Kubo, Shoji, Kumada, Takashi et al (show 5 more authors)
(2017)
Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide survey.
JOURNAL OF GASTROENTEROLOGY, 52 (10).
pp. 1112-1121.
Cucchetti, Alessandro, Zhong, Jianhong, Berhane, Sarah, Toyoda, Hidenori, Shi, KeQing, Tada, Toshifumi, Chong, Charing CN, Xiang, Bang-De, Li, Le-Qun, Lai, Paul BS et al (show 7 more authors)
(2019)
The chances of hepatic resection curing hepatocellular carcinoma.
Journal of hepatology, 72 (4).
pp. 711-717.